Main Session
Sep 29
QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation

1163 - Beyond NCCN: How a Prognostic and Predictive Multimodal AI Biomarker Drives ADT De-Escalation In Prostate Cancer

05:20pm - 05:25pm ET

Presenter(s)

Eric Wegener, MBBS - Genesis Cancer Care, Newcastle, NSW